Purpose: Atrial fibrillation (AF) is the most common heart arrhythmia and is associated with an increased risk of stroke. Stroke risk is commonly treated with oral anticoagulation (OAC) with a narrow therapeutic range (INR 2.0 to 3.0); which is poorly controlled in practice. Barriers to adherence include poor knowledge, and inaccurate perceptions surrounding illness and medications. Trial registration: ISRCTN93952605. Systematic review: Seven trials of educational, self-monitoring and decision aid interventions were included in a systematic review. Pooled analysis suggested education OR, 95% CI 7.89 (5.54-10.24) and self monitoring OR (95% CI) 5.47(2.55-8.39) significantly improve TTR; whereas decision aids are no more effective in reducing...
Objective - Atrial fibrillation (AF) patients are prescribed oral-anticoagulant (OAC) therapy, often...
YesIntroduction: Oral anticoagulant therapy choices for patients with atrial fibrillation (AF) expan...
Background: Oral anticoagulants (OACs) are prescribed to patients with atrial fibrillation (AF) in o...
Purpose: Atrial fibrillation (AF) is the most common heart arrhythmia and is associated with an incr...
Background: Stroke prevention in atrial fibrillation (AF), most commonly with warfarin, requires mai...
BACKGROUND: Stroke prevention in atrial fibrillation (AF), most commonly with warfarin, requires mai...
<div><p>Background</p><p>Stroke prevention in atrial fibrillation (AF), most commonly with warfarin,...
Background Current guidelines recommend oral anticoagulation therapy for patients with atrial fibril...
Background: Atrial fibrillation (AF) patients with a high risk of stroke are recommended anticoagula...
This article describes the theoretical and pragmatic development of a patient-centred intervention f...
Background Atrial fibrillation (AF) patients with a high risk of stroke are recommended anticoagulat...
This article describes the theoretical and pragmatic development of a patient-centred intervention f...
Background Oral anticoagulation is underused in patients with atrial fibrillation. We assessed the i...
Background: Oral anticoagulation (OAC) reduces stroke risk in patients with atrial fibrillation (AF)...
Objective - Atrial fibrillation (AF) patients are prescribed oral-anticoagulant (OAC) therapy, often...
YesIntroduction: Oral anticoagulant therapy choices for patients with atrial fibrillation (AF) expan...
Background: Oral anticoagulants (OACs) are prescribed to patients with atrial fibrillation (AF) in o...
Purpose: Atrial fibrillation (AF) is the most common heart arrhythmia and is associated with an incr...
Background: Stroke prevention in atrial fibrillation (AF), most commonly with warfarin, requires mai...
BACKGROUND: Stroke prevention in atrial fibrillation (AF), most commonly with warfarin, requires mai...
<div><p>Background</p><p>Stroke prevention in atrial fibrillation (AF), most commonly with warfarin,...
Background Current guidelines recommend oral anticoagulation therapy for patients with atrial fibril...
Background: Atrial fibrillation (AF) patients with a high risk of stroke are recommended anticoagula...
This article describes the theoretical and pragmatic development of a patient-centred intervention f...
Background Atrial fibrillation (AF) patients with a high risk of stroke are recommended anticoagulat...
This article describes the theoretical and pragmatic development of a patient-centred intervention f...
Background Oral anticoagulation is underused in patients with atrial fibrillation. We assessed the i...
Background: Oral anticoagulation (OAC) reduces stroke risk in patients with atrial fibrillation (AF)...
Objective - Atrial fibrillation (AF) patients are prescribed oral-anticoagulant (OAC) therapy, often...
YesIntroduction: Oral anticoagulant therapy choices for patients with atrial fibrillation (AF) expan...
Background: Oral anticoagulants (OACs) are prescribed to patients with atrial fibrillation (AF) in o...